Glenmark Life Sciences
-
Glenmark Pharma in definitive agreement with Nirma
To divest a 75 per cent stake in its subsidiary, Glenmark Life Sciences Glenmark Pharmaceuticals has entered into a definitive…
Read More » -
Glenmark’s arm files for IPO
The offer comprises a fresh issue of up to ₹1,160 crore and an offer-for-sale (OFS) of up to 73,05,245 equity…
Read More »